HenryFungMDFACP, FRCPE

PubMed

• 824 citations
  KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
  Michael Wang, Javier Munoz, Andre Goy, Frederick L. Locke, Caron A. Jacobson, Brian T. Hill, John M. Timmerman, Houston Holmes, Samantha Jaglowski, Ian W. Flinn, Peter...> ;The New England Journal of Medicine. 2020 Apr 1
• 148 citations
  Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
  Saad Z. Usmani, Fredrik Schjesvold, Albert Oriol, Lionel Karlin, Michele Cavo, Robert M Rifkin, Habte Aragaw Yimer, Richard Leblanc, Naoki Takezako, Robert Donald McCr...> ;The Lancet. Haematology. 2019 Sep 1
• 16 citations
  Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
  Andrew Kelly, Patricia Kropf, Henry C. Fung, Jaroslav Jelinek, Xiang Yao Su, Gail J. Roboz, Hagop M. Kantarjian, Mohammad Azab, Jean Pierre J. Issa> ;Clinical Epigenetics. 2019 Jul 22
• 10 citations
  Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors
  Camille N. Abboud, Nicole Lang, Henry C. Fung, Andreas Lammerich, Anton Buchner, Patrick Liu, Udo Mueller, Ruth Pettengell, Ingo Diel, Hartmut Link, Ashutosh Pathak> ;Supportive Care in Cancer. 2019 Jul 1
• 81 citations
  Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma.
  Stefan K. Barta, Jasmine Zain, Alexander W. MacFarlane, Sonali M. Smith, Jia Ruan, Henry C. Fung, Carlyn Rose C. Tan, Yibin Yang, R. Katherine Alpaugh, Essel Dulaimi, ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2019 Jun 1
• 34 citations
  Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
  Regina M. Myers, Brian T. Hill, Bronwen E. Shaw, Soyoung Kim, Heather R. Millard, Minoo Battiwalla, Navneet S. Majhail, David Buchbinder, Hillard M. Lazarus, Bipin N. ...> ;Cancer. 2018 Feb 15
• 2 citations
  The impact of posttraumatic stress symptoms on social support and social conflict during hematopoietic stem cell transplant.
  James I. Gerhart, Yasmin Asvat, Teresa A. Lillis, Henry C. Fung, Johanna Grosse, Stevan E. Hobfoll> ;Journal of Psychosocial Oncology. 2018 Feb 9
• 108 citations
  Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines
  Shaji Kumar, Natalie S. Callander, Melissa Alsina, Djordje Atanackovic, J. Sybil Biermann, Jorge J. Castillo, Jason C. Chandler, Caitlin Costello, Matthew Faiman, Henr...> ;Journal of the National Comprehensive Cancer Network. 2018 Jan 1
• 180 citations
  Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
  Lori Muffly, Marcelo C. Pasquini, Michael Martens, Ruta Brazauskas, Xiaochun Zhu, Kehinde Adekola, Mahmoud Aljurf, Karen K. Ballen, Ashish Bajel, Frédéric Baron, Minoo...> ;Blood. 2017 Aug 31
• 24 citations
  Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice.
  Qingrong Huang, Shan He, Yuanyuan Tian, Yuting Gu, Pan Chen, Changhong Li, Jiefang Huang, Yongnian Liu, Hongshuang Yu, Min Jin, Shaoyan Hu, Qing Tong, Anqi Ma, Jian Ji...> ;Blood. 2017 May 18
• 211 citations
  Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
  Shaji Kumar, Natalie S. Callander, Melissa Alsina, Djordje Atanackovic, J. Sybil Biermann, Jason C. Chandler, Caitlin Costello, Matthew Faiman, Henry C. Fung, Cristina...> ;Journal of the National Comprehensive Cancer Network. 2017 Feb 1
• Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.
  Scott EC, Hari P, Sharma M, Le-Rademacher J, Huang J, Vogl D, Abidi M, Beitinjaneh A, Fung H, Ganguly S, Hildebrandt G, Holmberg L, Kalaycio M, Kumar S, Kyle R, Lazaru...> ;Biol Blood Marrow Transplant. 2016 Oct
• NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.
  Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff C...> ;J Natl Compr Canc Netw. 2016-04-01
• The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation.
  Meng, L.,Bai, Z.,He, S.,Mochizuki, K.,Liu, Y.,Purushe, J.,Sun, H.,Wang, J.,Yagita, H.,Mineishi, S.,Fung, H.,Yanik, G. A.,Caricchio, R.,Fan, X.,Crisalli, L. M.,Hexner, ...> ;J. Immunol.. 2015 Dec 30
• Donor Lymphocyte Infusion in Hematologic Malignancies--Good to be Fresh?
  Hossain NM, Klumpp T, Ulicny J, Garner M, Kropf PL, Mangan KF, Barta SK, Fung HC, Martin ME> ;Clin Lymphoma Myeloma Leuk. 2016 Feb
• Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.
  Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff C...> ;J Natl Compr Canc Netw. 2015-11-01
• The Impact of Graft-Versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen
  Hillard M Lazarus, David G Maloney, Bipin N Savani, Henry C Fung, Taiga Nishihori, Lolie C Yu, Ran Reshef, Sonali M Smith, David J Inwards, Christopher Dandoy, Yoshihi...> ;Biology of Blood and Marrow Transplantation. 2015 May 20
• 9 citations
  Anger, provider responses, and pain: prospective analysis of stem cell transplant patients.
  James I. Gerhart, Veronica Sanchez Varela, John W. Burns, Henry C. Fung> ;Health Psychology. 2015 Mar 1
• Posttraumatic stress symptoms predict impaired neutrophil recovery in stem cell transplant recipients.
  Hobfoll SE Gerhart JI Zalta AK Wells K Maciejewski J Fung H> ;Psychooncology. 2015 Jan 27
• 9 citations
  Sequential single-agent obatoclax mesylate (GX15–070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma
  Andre Goy, Mark S. Berger, Peggy Ford, Tatyana Feldman, Anthony R. Mato, Henry C. Fung> ;Leukemia & Lymphoma. 2014 Mar 11
• A phase 1 dose-escalation study of XmAb 2513 in patients with relapsed or refractory Hodgkin lymphoma.
  Kumar A Blum KA Fung HC Smith MR Foster PA Younes A> ;Br J Haematol. 2014 Oct 1
• Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
  Sharma, M.,Zhang, M. J.,Zhong, X.,Abidi, M. H.,Akpek, G.,Bacher, U.,Callander, N. S.,Dispenzieri, A.,Freytes, C. O.,Fung, H. C.,Gale, R. P.,Gasparetto, C.,Gibson, J.,H...> ;Biol. Blood Marrow Transplant.. 2014 Jul 22
• Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
  Peksa, G. D.,Schultz, K.,Fung, H. C.> ;J Oncol Pharm Pract. 2014 Jun 19
• 7 citations
  Loss of CD26 Protease Activity in Recipient Mice during Hematopoietic Stem Cell Transplantation Results in Improved Transplant Efficiency
  Eunsun Yoo, Laura A. Paganessi, Wasfia A. Alikhan, Elizabeth A. Paganessi, Frank Hughes, Henry C. Fung, Elizabeth Rich, Chu Myong Seong, Kent W. Christopherson nd> ;Transfusion. 2013 Apr 1
• 11 citations
  Clinical and Safety Profile of High-Dose Interleukin-2 Treatment in Elderly Patients with Metastatic Melanoma and Renal Cell Carcinoma
  James M. Clark, Benjamin Kelley, Jill Titze, Henry C. Fung, John Maciejewski, Sunita Nathan, Elizabeth Rich, Sanjib Basu, Howard L. Kaufman> ;Oncology. 2013 Jan 1
• Join now to see all